NF-kappaB activation is required for adaptive cardiac hypertrophy. (Q45924674)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 20 July 2009

Language	Label	Description	Also known as
English	NF-kappaB activation is required for adaptive cardiac hypertrophy.	scientific article published on 20 July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

NF-kappaB activation is required for adaptive cardiac hypertrophy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

0 references

author name string

Laura Zelarayan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Anke Renger

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Claudia Noack

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Maria-Patapia Zafiriou

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Christina Gehrke

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Roel van der Nagel

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Rainer Dietz

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Leon de Windt

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Martin W Bergmann

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

publication date

20 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Cardiovascular Research

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

84

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

416-424

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

The fuzzy logic of physiological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Beta-catenin downregulation is required for adaptive cardiac remodeling

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Alterations in apoptosis regulatory factors during hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP237

21 January 2018

Identifiers

10.1093/CVR/CVP237

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19620128

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45924674&oldid=815701348"